D-Dimer Testing to Select Patients With a First Unprovoked Venous Thromboembolism Who Can Stop Anticoagulation Therapy

Journal of Vascular Surgery - United States
doi 10.1016/j.jvs.2015.04.409
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Economic Evaluation of Strategies for Restarting Anticoagulation Therapy After a First Event of Unprovoked Venous Thromboembolism

Journal of Thrombosis and Haemostasis
MedicineHematology
2017English

Utility of Plasma D-Dimer in Decision to Continue Anticoagulation Therapy Following Idiopathic Venous Thromboembolism

Kansas Journal of Medicine
2015English

D-Dimer Levels During and After Anticoagulation Withdrawal in Patients With Venous Thromboembolism Treated With Non-Vitamin K Anticoagulants

PLoS ONE
Multidisciplinary
2019English

Anticoagulation Treatment Using NOAC in Patients With Venous Thromboembolism

International Journal of Arrhythmia
2016English

A Risk Score for Prediction of Recurrence in Patients With Unprovoked Venous Thromboembolism (DAMOVES)

European Journal of Internal Medicine
Internal Medicine
2016English

Cancer Screening in Patients With Unprovoked Thromboembolism: How to Do It and Who Benefits?

Cureus
2020English

D-Dimer and High-Sensitivity C-Reactive Protein Levels to Predict Venous Thromboembolism Recurrence After Discontinuation of Anticoagulation for Cancer-Associated Thrombosis

British Journal of Cancer
Cancer ResearchOncology
2018English

Initial Anticoagulation Therapy in Patients With Venous Thromboembolism and Impaired Renal Function: Results of an Observational Study

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Anticoagulation for the Initial Treatment of Venous Thromboembolism in Patients With Cancer

Cochrane Database of Systematic Reviews
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy